In recent years, drug reformulation has emerged as a popular defence strategy among pharmaceutical companies seeking to prolong the life cycles of their best-selling products. It has also attracted growing interest from specialist companies developing novel formulations of off-patent drugs and which either launch them as replacements for the originator products, or reposition them for new indications.

ProStrakan will co-promote Gelclair, a mouth gel for relieving pain associated with oral mucositis, with EKR Therapeutics in the US to expand its business there.